Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,154 | 106,590 | 115,854 | 290,650 | 218,883 |
| Marketable Securities | 94,987 | 82,985 | 105,938 | 1,306 | 1,469 |
| Receivables | 40,120 | 31,792 | 98,240 | N/A | N/A |
| Inventories | 2,884 | 1,593 | N/A | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 981 |
| Other current assets | 111,182 | 131,123 | 0 | 84,615 | 58,398 |
| TOTAL | $398,031 | $355,056 | $320,705 | $377,178 | $282,710 |
| Non-Current Assets | |||||
| PPE Net | 38 | 16 | 18 | 22 | 31 |
| Investments And Advances | 0 | 0 | 75,000 | 0 | 0 |
| Intangibles | 630,860 | 637,883 | 339,338 | 354,881 | 399,204 |
| Other Non-Current Assets | 186,458 | 223,111 | 314,130 | 323,294 | 330,260 |
| TOTAL | $817,356 | $861,010 | $728,486 | $678,197 | $729,495 |
| Total Assets | $1,215,387 | $1,216,066 | $1,049,191 | $1,055,375 | $1,012,205 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,016 | 7,134 | 1,073 | 662 | 25,360 |
| Other current liabilities | 88,001 | 87,500 | N/A | N/A | N/A |
| TOTAL | $130,315 | $121,514 | $22,604 | $28,934 | $36,741 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 11,608 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 329,593 | 340,699 | 287,935 | 283,910 | 279,512 |
| TOTAL | $329,649 | $340,696 | $287,935 | $283,910 | $279,512 |
| Total Liabilities | $459,964 | $462,210 | $310,539 | $312,844 | $316,253 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,558 | 165,541 | 165,541 | 165,115 | 164,287 |
| Common Shares | 1,655 | 1,655 | 1,655 | 1,651 | 1,643 |
| Retained earnings | 857,116 | 867,442 | 853,539 | 857,667 | 810,036 |
| Other shareholders' equity | 4,280 | 4,227 | 0 | 418 | 2,256 |
| TOTAL | $755,423 | $753,856 | $738,652 | $742,531 | $695,952 |
| Total Liabilities And Equity | $1,215,387 | $1,216,066 | $1,049,191 | $1,055,375 | $1,012,205 |